The premenstrual syndrome

Br J Hosp Med. 1990 Oct;44(4):286-92.

Abstract

The recognition of the relationship between premenstrual syndrome and cyclical ovarian activity has enabled the rationalization of treatment. Placebo-controlled studies have established the efficacy of treatments that alter ovarian function, therefore it should no longer be necessary to rely on the placebo effect of unproven treatments such as progesterone.

Publication types

  • Review

MeSH terms

  • Contraceptives, Oral / therapeutic use
  • Danazol / therapeutic use
  • Estrogens / therapeutic use
  • Female
  • Gonadotropin-Releasing Hormone / therapeutic use
  • Humans
  • Premenstrual Syndrome / physiopathology*
  • Premenstrual Syndrome / psychology
  • Premenstrual Syndrome / therapy

Substances

  • Contraceptives, Oral
  • Estrogens
  • Gonadotropin-Releasing Hormone
  • Danazol